Levocetirizin + Pharma (Levocetirizine Dihydrochloride)

Levocetirizine works by selectively binding to peripheral H1‑histamine receptors on mast cells, basophils and other target cells. This antagonism blocks histamine from activating the receptors, preventing the cascade that leads to vasodilation, increased vascular permeability and nerve stimulation. The result is a reduction in typical allergy signs such as itching, swelling and nasal discharge without significant central nervous system penetration.

The exact dose of Levocetirizin + Pharma is determined by the prescribing healthcare professional. The prescriber considers factors such as the patient’s age, weight, renal function, severity of symptoms and any concomitant medications before selecting the appropriate strength and dosing interval. Patients should follow the individualized instructions provided on the prescription label.

Safety data for levocetirizine during pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant. Healthcare providers typically advise a careful risk‑benefit assessment and may recommend alternative therapies if safer options are available.

To order Levocetirizin + Pharma, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the sales team provides pricing, availability, shipping details—including any required cold‑chain handling—and assists with import documentation.

Levocetirizin + Pharma belongs to the second‑generation antihistamine class, offering similar efficacy to cetirizine but with a lower propensity for sedation due to its higher selectivity for peripheral H1 receptors. Compared with first‑generation antihistamines, it provides better tolerability and fewer anticholinergic effects, making it a preferred option for patients needing daytime allergy control.

Levocetirizin + Pharma should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original blister pack or container, protect them from moisture and direct sunlight, and ensure they are out of reach of children. Do not refrigerate or freeze the product, as this may affect tablet integrity.

The medication is administered orally, usually as a whole tablet swallowed with a glass of water. It can be taken with or without food, and patients should avoid crushing or chewing the tablet unless specifically instructed by a healthcare professional. Consistent daily intake at the same time of day helps maintain stable symptom control.

The most serious risks associated with Levocetirizin + Pharma include rare but potentially life‑threatening reactions such as anaphylaxis, Stevens‑Johnson syndrome and severe thrombocytopenia. Patients should be instructed to seek immediate medical attention if they experience symptoms like difficulty breathing, widespread skin blistering, or unexplained bruising or bleeding.

Levocetirizin + Pharma should not be used by individuals with known hypersensitivity to levocetirizine or any of its excipients. Caution is also advised for patients with severe renal impairment, pregnant or breastfeeding women unless clearly indicated, and those taking medications that may cause significant drug interactions. A healthcare professional should evaluate suitability before initiating therapy.